Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
STLE Annual MeetingSTLE Annual Meeting
Not Confirmed
Not Confirmed
18-22 May, 2025
Not Confirmed
Not Confirmed
19-22 May, 2025
Not Confirmed
Not Confirmed
20-22 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
STLE Annual MeetingSTLE Annual Meeting
Industry Trade Show
Not Confirmed
18-22 May, 2025
Industry Trade Show
Not Confirmed
19-22 May, 2025
Industry Trade Show
Not Confirmed
20-22 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions
31 Jan 2024
// Kevin Dunleavy FIERCE PHARMA
https://www.fiercepharma.com/pharma/fda-rejects-defenders-motion-sickness-nasal-gel-candidate#:~:text=A%20nasal%20gel%20version%20of%20the%20motion%20sickness%20drug%20scopolamine,and%20vomiting%20induced%20by%20motion.
30 Jan 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/01/30/2820312/0/en/Defender-Pharmaceuticals-Receives-Complete-Response-Letter-from-the-U-S-Food-and-Drug-Administration-for-its-Intranasal-Scopolamine-DPI-386-New-Drug-Application-for-the-Prevention-.html
24 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/24/2765559/0/en/Defender-Pharmaceuticals-Announces-Collaboration-with-NASA-on-Two-Phase-2-Clinical-Trials-Investigating-DPI-386-s-Ability-to-Mitigate-G-transition-Induced-Motion-Sickness-and-Enhan.html
26 Sep 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/09/26/2749419/0/en/FDA-Accepts-Defender-Pharmaceuticals-New-Drug-Application-for-Intranasal-Scopolamine-Gel.html
10 Aug 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/08/10/2722946/0/en/Defender-Pharmaceuticals-Phase-3-Motion-Sickness-Trial-Results-Selected-for-Presentation-at-2023-Military-Health-System-Research-Symposium-MHSRS.html
31 Jul 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/07/31/2715262/0/en/Defender-Pharmaceuticals-Announces-Exclusive-License-Agreement-with-the-U-S-Army-for-the-Development-of-Products-to-Treat-Tropical-Diseases.html
ABOUT THIS PAGE